EBOS Group: Keeping to the Script
EBOS GroupKeeping to the Script OUTPERFORM EBOS Group's (EBO) 1Q22 trading update confirmed a positive start to the year, with solid growth across...
289 Views
Company Coverage: Temporary Analyst Change
Company Coverage Temporary Analyst Change We temporarily transfer coverage of the following companies to Matt Montgomerie due to...
279 Views
Aussie Pharma (API AU): Sigma's Rival Bid (Just) Edges Wesfarmers
Trading slightly below Wesfarmer's cash proposal. That looks like a reasonable place to enter. Wesfarmers can easily trump any tilt from Sigma.
277 Views
EBOS Group: FY21 Result — Steady as She Goes
EBOS GroupFY21 Result — Steady as She Goes OUTPERFORM EBOS Group (EBO) reported a strong FY21 result, in line with our expectations, with growth...
669 Views
EBOS Group: FY21 Preview — Keep on Keeping On
EBOS GroupFY21 Preview — Keep on Keeping on OUTPERFORM We expect a strong FY21 result when EBOS Group (EBO) reports on Wednesday, 18 August. While...
562 Views